You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for diatrizoate meglumine; diatrizoate sodium and what is the scope of freedom to operate?

Diatrizoate meglumine; diatrizoate sodium is the generic ingredient in eighteen branded drugs marketed by Bayer Hlthcare, Intl Medication, Ge Healthcare, Mallinckrodt, Liebel-flarsheim, Bracco, Anda Repository, and Annora Pharma, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

Four suppliers are listed for this compound.

Summary for DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
US Patents:0
Tradenames:18
Applicants:8
NDAs:15
Finished Product Suppliers / Packagers: 4
DailyMed Link:DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM at DailyMed
Pharmacology for DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM

US Patents and Regulatory Information for DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco RENOGRAFIN-60 diatrizoate meglumine; diatrizoate sodium INJECTABLE;INJECTION 010040-006 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bracco GASTROGRAFIN diatrizoate meglumine; diatrizoate sodium SOLUTION;ORAL, RECTAL 011245-003 Approved Prior to Jan 1, 1982 AA RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bayer Hlthcare GASTROVIST diatrizoate meglumine; diatrizoate sodium SOLUTION;ORAL, RECTAL 087728-001 Sep 23, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ge Healthcare HYPAQUE-76 diatrizoate meglumine; diatrizoate sodium INJECTABLE;INJECTION 086505-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Annora Pharma DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM diatrizoate meglumine; diatrizoate sodium SOLUTION;ORAL, RECTAL 215049-001 Nov 17, 2023 AA RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.